And No Child Left Behind has forced attention on that because of the rules that the reporters on the first panel were talking about, and just because it's forced a national conversation about this.
Two days before, a panel at the American College of Cardiology had said that because an artery-imaging study showed no added benefit from Zetia to Zocor, doctors should dramatically scale back their use of Zetia and Vytorin.